Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis.

Lee BY, Bailey RR, Smith KJ, Muder RR, Strotmeyer ES, Lewis GJ, Ufberg PJ, Song Y, Harrison LH.

Infect Control Hosp Epidemiol. 2010 Jun;31(6):598-606. doi: 10.1086/652524.


Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals.

Leonhardt KK, Yakusheva O, Phelan D, Reeths A, Hosterman T, Bonin D, Costello M.

Infect Control Hosp Epidemiol. 2011 Aug;32(8):797-803. doi: 10.1086/660875.


Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting.

Kang J, Mandsager P, Biddle AK, Weber DJ.

Infect Control Hosp Epidemiol. 2012 May;33(5):477-86. doi: 10.1086/665315. Epub 2012 Mar 21. Review.


Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.

Gidengil CA, Gay C, Huang SS, Platt R, Yokoe D, Lee GM.

Infect Control Hosp Epidemiol. 2015 Jan;36(1):17-27. doi: 10.1017/ice.2014.12.


Screening cardiac surgery patients for MRSA: an economic computer model.

Lee BY, Wiringa AE, Bailey RR, Goyal V, Lewis GJ, Tsui BY, Smith KJ, Muder RR.

Am J Manag Care. 2010 Jul 1;16(7):e163-73.


Review of a two-year methicillin-resistant Staphylococcus aureus screening program and cost-effectiveness analysis in Singapore.

Win MK, Soliman TA, Lee LK, Wong CS, Chow A, Ang B, Roman CL, Leo YS.

BMC Infect Dis. 2015 Sep 29;15:391. doi: 10.1186/s12879-015-1131-5.


Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.

Robotham JV, Deeny SR, Fuller C, Hopkins S, Cookson B, Stone S.

Lancet Infect Dis. 2016 Mar;16(3):348-56. doi: 10.1016/S1473-3099(15)00417-X. Epub 2015 Nov 28.


Cost-effectiveness of universal MRSA screening on admission to surgery.

Murthy A, De Angelis G, Pittet D, Schrenzel J, Uckay I, Harbarth S.

Clin Microbiol Infect. 2010 Dec;16(12):1747-53. doi: 10.1111/j.1469-0691.2010.03220.x.


Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation.

Robotham JV, Graves N, Cookson BD, Barnett AG, Wilson JA, Edgeworth JD, Batra R, Cuthbertson BH, Cooper BS.

BMJ. 2011 Oct 5;343:d5694. doi: 10.1136/bmj.d5694.


Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?

Lee BY, Tsui BY, Bailey RR, Smith KJ, Muder RR, Lewis GJ, Harrison LH.

Infect Control Hosp Epidemiol. 2009 Dec;30(12):1158-65. doi: 10.1086/648087.


Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.

Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, King P, Peterson LR.

Ann Intern Med. 2008 Mar 18;148(6):409-18.


The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA.

Lee BY, Song Y, McGlone SM, Bailey RR, Feura JM, Tai JH, Lewis GJ, Wiringa AE, Smith KJ, Muder RR, Harrison LH, Piraino B.

Clin Microbiol Infect. 2011 Nov;17(11):1717-26. doi: 10.1111/j.1469-0691.2011.03525.x. Epub 2011 May 20.


Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureus.

Gurieva T, Bootsma MC, Bonten MJ.

PLoS Comput Biol. 2013;9(2):e1002874. doi: 10.1371/journal.pcbi.1002874. Epub 2013 Feb 21.


Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.

McKinnell JA, Bartsch SM, Lee BY, Huang SS, Miller LG.

Infect Control Hosp Epidemiol. 2015 Jan;36(1):2-13. doi: 10.1017/ice.2014.1.


The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.

Lee BY, Wiringa AE, Bailey RR, Goyal V, Tsui B, Lewis GJ, Muder RR, Harrison LH.

Infect Control Hosp Epidemiol. 2010 Nov;31(11):1130-8. doi: 10.1086/656591. Erratum in: Infect Control Hosp Epidemiol. 2011 Jan;32(1):99. Harrison, Lee M [corrected to Harrison, Lee H].


Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission.

McKinnell JA, Huang SS, Eells SJ, Cui E, Miller LG.

Infect Control Hosp Epidemiol. 2013 Feb;34(2):161-70. doi: 10.1086/669095. Epub 2012 Dec 21. Review.


Clinical, patient experience and cost impacts of performing active surveillance on known methicillin-resistant Staphylococcus aureus positive patients admitted to medical-surgical units.

Goldsack JC, DeRitter C, Power M, Spencer A, Taylor CL, Kim SF, Kirk R, Drees M.

Am J Infect Control. 2014 Oct;42(10):1039-43. doi: 10.1016/j.ajic.2014.07.011.


Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission.

Morgan DJ, Day HR, Furuno JP, Young A, Johnson JK, Bradham DD, Perencevich EN.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1230-5. doi: 10.1086/657335. Epub 2010 Oct 28.


Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later.

Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo CM, Farr BM.

Infect Control Hosp Epidemiol. 1995 Dec;16(12):686-96.


Collateral benefit of screening patients for methicillin-resistant Staphylococcus aureus at hospital admission: isolation of patients with multidrug-resistant gram-negative bacteria.

Jones M, Nielson C, Gupta K, Khader K, Evans M.

Am J Infect Control. 2015 Jan;43(1):31-4. doi: 10.1016/j.ajic.2014.09.016. Epub 2014 Nov 7.


Supplemental Content

Support Center